Daily Oncology News

Critical illnesses have a significant impact on overall survival among patients with cancer

Critical illnesses have a significant impact on overall survival among patients with cancer

1 in 20 patients with cancer were admitted to the intensive care unit (ICU) for a critical illness within 2 years of their diagnosis.

If severe toxicity does not affect daily living, clinicians may not modify treatment

If severe toxicity does not affect daily living, clinicians may not modify treatment

If a severe toxicity does not have a long duration of impact on elderly patients, oncologists are less inclined to modify treatment.

Religious, spiritual statements during ICU goals-of-care discussions important

Religious, spiritual statements during ICU goals-of-care discussions important

Discussion of religious or spiritual considerations occurred in fewer than 20% of goals-of-care conferences in intensive care units.

Research group looking to bring Cuba's lung cancer vaccine to the United States

Research group looking to bring Cuba's lung cancer vaccine to the United States

As relations between the United States and Cuba normalize, groundbreaking lung cancer research and a vaccine may be early imports.

Patients with advanced cancer prefer open, effective communication

Patients with advanced cancer prefer open, effective communication

A majority of patients with advanced cancer preferred that their physicians be realistic about their future.

26 percent of senior oncology patients use alternative therapies

26 percent of senior oncology patients use alternative therapies

More than a quarter of senior oncology patients use complementary or alternative medicines (CAM).

Older, younger patients with metastatic pancreatic cancer have similar survival

Older, younger patients with metastatic pancreatic cancer have similar survival

Older patients metastatic pancreatic cancer are less likely to receive chemotherapy compared with younger patients with metastatic disease.

Longer colonoscopy withdrawal times associated with lower cancer rate

Longer colonoscopy withdrawal times associated with lower cancer rate

Colonoscopy withdrawal times of 6 minutes or more are associated with lower colon cancer rates.

Safest timing of pegfilgrastim administration seems to be 72 hours after chemo

Safest timing of pegfilgrastim administration seems to be 72 hours after chemo

Safest timing of pegfilgrastim administration based on white blood cell (WBC) count seems to be 72 hours following chemotherapy.

Efficacy, safety of biosimilar filgrastim similar to that of filgrastim in daily practice

Efficacy, safety of biosimilar filgrastim similar to that of filgrastim in daily practice

Effectiveness and safety of biosimilar filgrastim (Zarxio) in daily clinical practice are similar to that of the originator filgrastim.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs